This trial is testing whether a drug called rapamycin can treat vitiligo. People will apply it to one side of their body and a placebo to the other to see if there's a difference. The study will also see if patients are happy with the treatment and if there are any side effects.
3 Primary · 1 Secondary · Reporting Duration: 6 months
Active Control
Experimental Treatment
Non-Treatment Group
20 Total Participants · 3 Treatment Groups
Primary Treatment: Rapamycin · Has Placebo Group · Phase 2
Age Any Age · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Nevada | 33.3% |
Arizona | 16.7% |
New Jersey | 16.7% |
Other | 33.3% |
18 - 65 | 66.7% |
< 18 | 33.3% |
Medical University of South Carolina | 100.0% |
Did not meet criteria | 33.3% |
Met criteria | 66.7% |
100.0% | |